News

AVANT BIO Leads Series B Investment in Abbelight

Abbelight, a pioneer in super-resolution microscopy and bioinformatics, announced that it has closed a Series B financing round led by AVANT BIO. The financing will support Abbelight’s global expansion and continued innovation across its nanoscale imaging and data analysis platform.

Abbelight’s modular technology combines advanced imaging hardware with scalable bioinformatics, delivering an end-to-end workflow that enables researchers to visualize, quantify, and interpret biological systems at the nanoscale. By bridging high-resolution visualization with actionable data, the platform is transforming how scientists generate insights critical to therapeutic discovery.

Founded in France, Abbelight has built a differentiated position in the life sciences tools ecosystem by uniting expertise across chemistry, optics, and computer engineering. Its solutions are used by researchers at leading academic institutions and biotechnology companies worldwide, supporting applications ranging from fundamental research to translational science.

AVANT BIO is proud to support Abbelight’s mission to democratize access to advanced nanoscale imaging and quantitative analysis, empowering scientists to push the boundaries of what is visible and measurable in biology.

Read Abbelight’s press release here.

Please follow Abbelight on LinkedIn to stay up to date on the company’s latest developments. Visit Abbelight to learn more about their technology.